| Stoddard Baptist Nursing Home | |
| 1818 Newton St. Nw, Washington, District Of Columbia 20010 | |
| (202) 328-7400 | |
| Name | Stoddard Baptist Nursing Home |
|---|---|
| Location | 1818 Newton St. Nw, Washington, District Of Columbia |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 164 |
| Occupancy Rate | 60.79% |
| Medicare ID (CCN) | 095020 |
| Legal Business Name | Stoddard Baptist Home |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1336991959 |
| Organization Name | NU PATHWAY HEALTHCARE AND WELLNESS LLC |
| Address | 1818 Newton St Nw, Washington, DC 20010 |
| Phone Number | 202-932-8149 |
News Archive
The Allen Institute for Cell Science today launched the first predictive and comprehensive, 3D model of a live human cell, the Allen Integrated Cell.
In a promising development for diabetes treatment, researchers have developed a network of nanoscale particles that can be injected into the body and release insulin when blood-sugar levels rise, maintaining normal blood sugar levels for more than a week in animal-based laboratory tests.
Osaka University Hospital began Japan's first clinical research for diagnosis of prostate cancer using PET (positron emission tomography) scan results in September 2019.
A new drug, eprotirome, has been shown to significantly lower bad cholesterol, triglycerides and Lp(A), without the side effects that statins cause in many people. Results of a study were published today in the New England Journal of Medicine.
Harvard stem cell scientists have discovered that a recently approved medication for epilepsy may possibly be a meaningful treatment for amyotrophic lateral sclerosis (ALS)-Lou Gehrig's disease, a uniformly fatal neurodegenerative disorder. The researchers are now collaborating with Massachusetts General Hospital to design an initial clinical trial testing the safety of the treatment in ALS patients.
› Verified 6 days ago
| NPI Number | 1851618714 |
| Organization Name | STODDARD BAPTIST GLOBAL CARE |
| Address | 2601 18th St Ne, Washington, DC 20018 |
| Phone Number | 202-328-7400 |
News Archive
The Allen Institute for Cell Science today launched the first predictive and comprehensive, 3D model of a live human cell, the Allen Integrated Cell.
In a promising development for diabetes treatment, researchers have developed a network of nanoscale particles that can be injected into the body and release insulin when blood-sugar levels rise, maintaining normal blood sugar levels for more than a week in animal-based laboratory tests.
Osaka University Hospital began Japan's first clinical research for diagnosis of prostate cancer using PET (positron emission tomography) scan results in September 2019.
A new drug, eprotirome, has been shown to significantly lower bad cholesterol, triglycerides and Lp(A), without the side effects that statins cause in many people. Results of a study were published today in the New England Journal of Medicine.
Harvard stem cell scientists have discovered that a recently approved medication for epilepsy may possibly be a meaningful treatment for amyotrophic lateral sclerosis (ALS)-Lou Gehrig's disease, a uniformly fatal neurodegenerative disorder. The researchers are now collaborating with Massachusetts General Hospital to design an initial clinical trial testing the safety of the treatment in ALS patients.
› Verified 6 days ago
| NPI Number | 1962559104 |
| Organization Name | STODDARD BAPTIST HOME |
| Doing Business As | STODDARD BAPTIST NURSING HOME |
| Address | 1818 Newton St Nw, Washington, DC 20010 |
| Phone Number | 202-328-7400 |
News Archive
The Allen Institute for Cell Science today launched the first predictive and comprehensive, 3D model of a live human cell, the Allen Integrated Cell.
In a promising development for diabetes treatment, researchers have developed a network of nanoscale particles that can be injected into the body and release insulin when blood-sugar levels rise, maintaining normal blood sugar levels for more than a week in animal-based laboratory tests.
Osaka University Hospital began Japan's first clinical research for diagnosis of prostate cancer using PET (positron emission tomography) scan results in September 2019.
A new drug, eprotirome, has been shown to significantly lower bad cholesterol, triglycerides and Lp(A), without the side effects that statins cause in many people. Results of a study were published today in the New England Journal of Medicine.
Harvard stem cell scientists have discovered that a recently approved medication for epilepsy may possibly be a meaningful treatment for amyotrophic lateral sclerosis (ALS)-Lou Gehrig's disease, a uniformly fatal neurodegenerative disorder. The researchers are now collaborating with Massachusetts General Hospital to design an initial clinical trial testing the safety of the treatment in ALS patients.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The Allen Institute for Cell Science today launched the first predictive and comprehensive, 3D model of a live human cell, the Allen Integrated Cell.
In a promising development for diabetes treatment, researchers have developed a network of nanoscale particles that can be injected into the body and release insulin when blood-sugar levels rise, maintaining normal blood sugar levels for more than a week in animal-based laboratory tests.
Osaka University Hospital began Japan's first clinical research for diagnosis of prostate cancer using PET (positron emission tomography) scan results in September 2019.
A new drug, eprotirome, has been shown to significantly lower bad cholesterol, triglycerides and Lp(A), without the side effects that statins cause in many people. Results of a study were published today in the New England Journal of Medicine.
Harvard stem cell scientists have discovered that a recently approved medication for epilepsy may possibly be a meaningful treatment for amyotrophic lateral sclerosis (ALS)-Lou Gehrig's disease, a uniformly fatal neurodegenerative disorder. The researchers are now collaborating with Massachusetts General Hospital to design an initial clinical trial testing the safety of the treatment in ALS patients.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $650 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 20.8 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7.71 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 82.2 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.15 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.06 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0.72 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 93.48 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 1.32 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 49.14 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 46.99 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 11.46 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 10.61 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.07 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 13.07 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 68.46 | 82.93 |
News Archive
The Allen Institute for Cell Science today launched the first predictive and comprehensive, 3D model of a live human cell, the Allen Integrated Cell.
In a promising development for diabetes treatment, researchers have developed a network of nanoscale particles that can be injected into the body and release insulin when blood-sugar levels rise, maintaining normal blood sugar levels for more than a week in animal-based laboratory tests.
Osaka University Hospital began Japan's first clinical research for diagnosis of prostate cancer using PET (positron emission tomography) scan results in September 2019.
A new drug, eprotirome, has been shown to significantly lower bad cholesterol, triglycerides and Lp(A), without the side effects that statins cause in many people. Results of a study were published today in the New England Journal of Medicine.
Harvard stem cell scientists have discovered that a recently approved medication for epilepsy may possibly be a meaningful treatment for amyotrophic lateral sclerosis (ALS)-Lou Gehrig's disease, a uniformly fatal neurodegenerative disorder. The researchers are now collaborating with Massachusetts General Hospital to design an initial clinical trial testing the safety of the treatment in ALS patients.
› Verified 6 days ago
Washington Ctr For Aging Svcs Location: 2601 18th Street Ne, Washington, District Of Columbia 20018 Phone: (202) 541-6140 | |
Serenity Rehabilitation And Health Center Llc Location: 1380 Southern Ave Se, Washington, District Of Columbia 20032 Phone: (202) 279-5880 | |
Deanwood Rehabilitation And Wellness Center Location: 5000 Burroughs Ave. Ne, Washington, District Of Columbia 20019 Phone: (202) 399-7504 | |
Stoddard Baptist Nursing Home Location: 1818 Newton St. Nw, Washington, District Of Columbia 20010 Phone: (202) 328-7400 | |
Capitol City Rehab And Healthcare Center Location: 2425 25th Street Se, Washington, District Of Columbia 20020 Phone: (202) 889-3600 | |
Bridgepoint Subacute And Rehab National Harbor Location: 4601 Martin Luther King Jr Avenue Sw, Washington, District Of Columbia 20032 Phone: (202) 279-3005 |